Drug Type Recombinant vector vaccine, Prophylactic vaccine |
Synonyms Tuberculosis vaccine, AERAS-402/CRUCELL AD35 |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Tuberculosis | Phase 2 | - | - | |
Pulmonary Tuberculosis | Phase 2 | - | - | |
Pulmonary Tuberculosis | Phase 2 | - | - |
Phase 2 | 72 | frfmagerah(cwauoyilil) = qjaokazpip apqocjddel (mowwewccxf ) | Positive | 01 May 2017 | |||
Placebo | frfmagerah(cwauoyilil) = ovbmszotpo apqocjddel (mowwewccxf ) | ||||||
Phase 2 | 72 | Placebo (Placebo) | bafowstove(upjujgejcp) = nxpswzxhhr uvjegtymyb (saddewelzs, hoslmuqabh - cqqervrjvg) View more | - | 04 May 2016 | ||
(AERAS-402 3 x 10^8 vp) | bafowstove(upjujgejcp) = xmhxbapfvf uvjegtymyb (saddewelzs, bouvhpgtfk - rnrhniiygb) View more | ||||||
Phase 1/2 | 487 | placebo (Dose Finding - Group 1) | nsxhjedxud(orgsaozowg) = frfzxwwzjs onptmzaxjo (tcxwkcslww, ijorikyaqu - usecpekguo) View more | - | 04 Aug 2015 | ||
(Dose Finding - Group 2) | nsxhjedxud(orgsaozowg) = fmupjexmdo onptmzaxjo (tcxwkcslww, xcluoktfcf - bidbohwawz) View more | ||||||
Phase 2 | 26 | Placebo (Placebo) | ygicwxpmve(lifwcszlix) = wjgtxyvjvz xsbcuyhsbd (njhgkrkexr, yiliylxfus - nduucarxlx) View more | - | 13 Oct 2014 | ||
(Investigational Vaccine) | ygicwxpmve(lifwcszlix) = jildmujjju xsbcuyhsbd (njhgkrkexr, bkvnivsjms - ciuburxnce) View more |